研究单位：[1]Akeso[2]The Second Affiliated Hospital of Wannan Medical College,Wuhu,Anhui,China[3]Peking University People's Hospital,Beijing,Beijing,China[4]Chongqing Traditional Chinese Medicine Hospital,Chongqing,Chongqing,China[5]The First Affiliated Hospital of Chongqing Medical University,Chongqing,Chongqing,China[6]Dongguan People's Hospital,Dongguan,Guangdong,China[7]Dermatology Hospital of Southern Medical University,Guangzhou,Guangdong,China[8]Sun Yat-sen Memorial Hospital, Sun Yat-sen University,Guangzhou,Guangdong,China[9]The First Affiliated Hospital of Jinan University,Guangzhou,Guangdong,China[10]The Second Affiliated Hospital of Guangzhou Medical University,Guangzhou,Guangdong,China[11]Jiangmen Central Hospital,Jiangmen,Guangdong,China[12]The University of Hong Kong - Shenzhen Hospital,Shenzhen,Guangdong,China[13]The Third People's Hospital of Zhuhai,Zhuhai,Guangdong,China[14]Liuzhou Worker's Hospital,Liuzhou,Guangxi,China[15]Jinzhou Central Hospital,Jinzhou,Hubei,China[16]Tongji Hospital,Wuhan,Hubei,China[17]Hunan Children's Hospital,Changsha,Hunan,China[18]XiangYa Hospital CentralSouth University,Changsha,Hunan,China[19]Affiliated Hospital of Jiangsu University,Zhenjiang,Jiangsu,China[20]Dermatology Hospital of Jiangxi Province,Nanchang,Jiangxi,China[21]Shandong Provincial Dermatology Hospital,Jinan,Shandong,China[22]Jining First People's Hospital,Jining,Shandong,China[23]Huashan Hospital, Fudan University,Shanghai,Shanghai,China[24]Longhua Hospital Shanghai University of Traditional Chinese Medicine,Shanghai,Shanghai,China[25]Shanghai Skin Disease Hospital,Shanghai,Shanghai,China[26]The First Affiliated Hospital of Xi'an Jiao Tong University,Xi'an,Shanxi,China[27]Sichuan Provincial People's Hospital,Chengdu,Sichuan,China[28]The First Affiliated Hospital of Kunming Medical University,Kunming,Yunnan,China[29]The First Hospital of Jiaxing,Jiaxing,Zhejiang,China
研究目的：
This is a randomized double-blind, placebo-controlled, multicenter phase III clinical study evaluating the efficacy and safety of AK120 in the treatment of moderate-to-severe AD in adolescents.
